Fidelity Advisor Biotechnology Fund - Class A (FBTAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
27.27
+0.01 (0.04%)
Mar 7, 2025, 8:02 PM EST
FBTAX Holdings List
As of Dec 31, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ABBV | AbbVie Inc. | 21.42% |
2 | REGN | Regeneron Pharmaceuticals, Inc. | 6.23% |
3 | AMGN | Amgen Inc. | 5.86% |
4 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.23% |
5 | VRTX | Vertex Pharmaceuticals Incorporated | 4.62% |
6 | ARGX | argenx SE | 4.52% |
7 | ASND | Ascendis Pharma A/S | 3.85% |
8 | PCVX | Vaxcyte, Inc. | 2.25% |
9 | VRDN | Viridian Therapeutics, Inc. | 1.93% |
10 | NUVL | Nuvalent, Inc. | 1.90% |
11 | VKTX | Viking Therapeutics, Inc. | 1.86% |
12 | SRRK | Scholar Rock Holding Corporation | 1.85% |
13 | XENE | Xenon Pharmaceuticals Inc. | 1.79% |
14 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.78% |
15 | CYTK | Cytokinetics, Incorporated | 1.62% |
16 | ACLX | Arcellx, Inc. | 1.54% |
17 | MRUS | Merus N.V. | 1.41% |
18 | APGE | Apogee Therapeutics, Inc. | 1.37% |
19 | JANX | Janux Therapeutics, Inc. | 1.35% |
20 | EXAS | Exact Sciences Corporation | 1.32% |
21 | NRIX | Nurix Therapeutics, Inc. | 1.26% |
22 | RVMD | Revolution Medicines, Inc. | 1.06% |
23 | ELVN | Enliven Therapeutics, Inc. | 0.98% |
24 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.97% |
25 | SYRE | Spyre Therapeutics, Inc. | 0.96% |
26 | EBR: UCB | UCB SA | 0.92% |
27 | CLDX | Celldex Therapeutics, Inc. | 0.72% |
28 | MLTX | MoonLake Immunotherapeutics | 0.71% |
29 | DNTH | Dianthus Therapeutics, Inc. | 0.70% |
30 | SRPT | Sarepta Therapeutics, Inc. | 0.70% |
31 | n/a | Bridgebio Pharma Inc Pipe | 0.69% |
32 | COGT | Cogent Biosciences, Inc. | 0.67% |
33 | DNLI | Denali Therapeutics Inc. | 0.65% |
34 | DAWN | Day One Biopharmaceuticals, Inc. | 0.65% |
35 | TVTX | Travere Therapeutics, Inc. | 0.59% |
36 | GPCR | Structure Therapeutics Inc. | 0.57% |
37 | ATXS | Astria Therapeutics, Inc. | 0.56% |
38 | APLS | Apellis Pharmaceuticals, Inc. | 0.55% |
39 | IMVT | Immunovant, Inc. | 0.52% |
40 | ORKA | Oruka Therapeutics, Inc. | 0.51% |
41 | IRON | Disc Medicine, Inc. | 0.50% |
42 | GLUE | Monte Rosa Therapeutics, Inc. | 0.44% |
43 | TECX | Tectonic Therapeutic, Inc. | 0.42% |
44 | ALLK | Allakos Inc. | 0.38% |
45 | n/a | Sonoma Biotherap Ser B Pfd Pp | 0.36% |
46 | ANAB | AnaptysBio, Inc. | 0.36% |
47 | n/a | Crescent Biopharma Inc Pipe | 0.36% |
48 | DYN | Dyne Therapeutics, Inc. | 0.35% |
49 | CRGX | CARGO Therapeutics, Inc. | 0.35% |
50 | CATX | Perspective Therapeutics, Inc. | 0.34% |
51 | SLNO | Soleno Therapeutics, Inc. | 0.33% |
52 | BCAX | Bicara Therapeutics Inc. | 0.32% |
53 | LEGN | Legend Biotech Corporation | 0.30% |
54 | NMRA | Neumora Therapeutics, Inc. | 0.30% |
55 | ZLAB | Zai Lab Limited | 0.29% |
56 | AUTL | Autolus Therapeutics plc | 0.29% |
57 | AXSM | Axsome Therapeutics, Inc. | 0.29% |
58 | ALLO | Allogene Therapeutics, Inc. | 0.28% |
59 | ANNX | Annexon, Inc. | 0.26% |
60 | KROS | Keros Therapeutics, Inc. | 0.25% |
61 | CTNM | Contineum Therapeutics, Inc. | 0.25% |
62 | n/a | Oruka Therapeutics Inc Pipe | 0.25% |
63 | MLYS | Mineralys Therapeutics, Inc. | 0.24% |
64 | SMMT | Summit Therapeutics Inc. | 0.23% |
65 | THRD | Third Harmonic Bio, Inc. | 0.23% |
66 | ZBIO | Zenas BioPharma, Inc. | 0.22% |
67 | n/a | Endeavor Biomedici Ser C Pc Pp | 0.22% |
68 | n/a | Sonoma Biotherap Ser B1 Pfd Pp | 0.22% |
69 | n/a | Tectonic Therapeutic Inc Pipe | 0.22% |
70 | RAPP | Rapport Therapeutics, Inc. | 0.21% |
71 | n/a | Bright Peak Thera Ser B Pc Pp | 0.20% |
72 | UPB | Upstream Bio, Inc. | 0.20% |
73 | SVRA | Savara Inc. | 0.19% |
74 | n/a | Kartos Therapeutic Ser C Pc Pp | 0.19% |
75 | WVE | Wave Life Sciences Ltd. | 0.18% |
76 | TYRA | Tyra Biosciences, Inc. | 0.18% |
77 | CGON | CG Oncology, Inc. | 0.15% |
78 | n/a | Wugen Inc Ser B Pc Pp | 0.14% |
79 | n/a | T-Knife Therapeutics B Pc Pp | 0.11% |
80 | n/a | Candid Therapeutic Ser B Pc Pp | 0.11% |
81 | n/a | Enliven Therapeutics Pipe | 0.11% |
82 | BBIO | BridgeBio Pharma, Inc. | 0.11% |
83 | n/a | Cardurion Pharmace Ser B Pc Pp | 0.10% |
84 | n/a | Parabilis Medicines Inc Ser D | 0.09% |
85 | n/a | Lifemine Therapeutics Ser C Pp | 0.09% |
86 | NGNE | Neurogene Inc. | 0.09% |
87 | n/a | Warrant on Astria Therapeutics Inc | 0.06% |
88 | n/a | Bright Peak Therapeutics Ser C | 0.06% |
89 | n/a | Wugen Inc Conv 10% 06/14/25 Pp | 0.06% |
90 | n/a | Jade Biosciences Inc Pipe | 0.05% |
91 | BOLD | Boundless Bio, Inc. | 0.04% |
92 | n/a | Treeline Biosci Ser A Pc Pp | 0.02% |
93 | n/a | Fidelity Cash Central Fund | 0.02% |
94 | n/a | Scholar Rock Wt 12/31/25 Pp | 0.01% |
95 | n/a | Warrant on Enliven Therapeutics Inc | 0.00% |
96 | n/a | Afferent Pharma Ser C Pc Pp | 0.00% |
97 | n/a | Cash | -0.26% |
As of Dec 31, 2024